[PHAS] YoY Quarter Result on 31-Mar-2018 [#Q1]

Stock
[PHAS] PhaseBio Pharmaceuticals, Inc.
Announcement Date
30-Mar-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -73.69%
YoY-
Quarter Report
PHAS's Result
PHAS's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 117 0 320 653 0 -
PBT -11,141 -27,358 -14,905 -7,293 -4,403 26.10%
Tax 148 -1,426 -239 317 -121 -
NP -11,289 -27,358 -14,905 -7,293 -4,403 26.51%
Tax Rate - - - - - -
Total Cost 11,406 27,358 15,225 7,946 4,403 26.84%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -9,648.72 0.00 -4,657.81 -1,116.85 0.00 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.23 -0.87 -0.52 -0.30 -0.36 -10.58%
EPS Diluted -0.23 -0.87 -0.52 -0.30 -0.36 -10.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.